<DOC>
<DOCNO>EP-0644883</DOCNO> 
<TEXT>
<INVENTION-TITLE>
ENNIATINES AND ENNIATINE DERIVATES USED TO CONTROL ENDOPARASITES
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C23300	C07C27100	C07C27122	A61P3100	C07C22922	A61P3300	C07C23336	A61P3300	A61K31395	C07C22914	C07C22912	C07C23102	C07C23500	C07D27300	C07C23100	A61P3100	C07C22900	C07C23512	C07C22934	C07D27300	A61K31395	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	C07C	C07C	A61P	C07C	A61P	C07C	A61P	A61K	C07C	C07C	C07C	C07C	C07D	C07C	A61P	C07C	C07C	C07C	C07D	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C233	C07C271	C07C271	A61P31	C07C229	A61P33	C07C233	A61P33	A61K31	C07C229	C07C229	C07C231	C07C235	C07D273	C07C231	A61P31	C07C229	C07C235	C07C229	C07D273	A61K31	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Use of cyclic depsipeptides having 18 ring atoms of
the general formula (I)



in which

R
1
, R
3
 and R
5
independently of one another represent
straight-chain or branched alkyl having up to

8 carbon atoms, cycloalkylalkyl and optionally
substituted phenyl-C
1
-C
4
-alkyl, substituents
which may be mentioned being halogen,

hydroxyl, alkyl or alkoxy,
R
2
 , R
4
 and R
6
independently of one another represent
straight-chain or branched alkyl having up to

8 carbon atoms, cycloalkylalkyl and optionally
substituted phenyl-C
1
-C
4
-alkyl, substituents 
which may be mentioned being halogen,

hydroxyl, alkyl or alkoxy,

and their optical isomers and racemates,

in medicine and veterinary medicine for the
preparation of compositions for combating

endoparasites.
Cyclic depsipeptides having 18 ring atoms of the
general formula (Ia)



in which

R
1
represents straight-chain or branched alkyl
having 2 to 8 carbon atoms or cycloalkylalkyl
R
3
 and R
5
independently of one another represent
straight-chain or branched alkyl having up to

8 carbon atoms, cycloalkylalkyl and optionally
substituted phenyl-C
1
-C
4
-alkyl, substituents
which may be mentioned being halogen,

hydroxyl, alkyl or alkoxy,
R
4
 and R
6
independently of one another represent
straight-chain or branched alkyl having up to 

8 carbon atoms, cycloalkylalkyl and optionally
substituted phenyl-C
1
-C
4
-alkyl, substituents
which may be mentioned being halogen,

hydroxyl, alkyl or alkoxy,

and their optical isomers and racemates,
except for the compound of the formula (Ia) in

which the radicals R
1
, R
3
, R
4
, R
5
 and R
6

represent i-propyl.
Process for the preparation of cyclic depsipeptides
having 18 ring atoms of the general formula (Ia)

according to Claim 2


in which

R
1
represents straight-chain or branched alkyl
having 2 to 8 carbon atoms cycloalkylalkyl,
R
3
 and R
5
independently of one another represent
straight-chain or branched alkyl having up to

8 carbon atoms, cycloalkylalkyl and optionally
substituted phenyl-C
1
-C
4
-alkyl, substituents
which may be mentioned being halogen,

hydroxyl, alkyl or alkoxy, 
R
4
 and R
6
independently of one another represent
straight-chain or branched alkyl having up to

8 carbon atoms, cycloalkylalkyl and optionally
substituted phenyl-C
1
-C
4
-alkyl, substituents
which may be mentioned being halogen,

hydroxyl, alkyl or alkoxy,

characterized in that

a) carboxyl-activated open-chain hexadepsipeptides
of the general formula (IIc)



in which

A
represents an amino protective group which can
be detached selectively with reg
ard to the
active ester protecting group, such as benzyl

or benzyloxycarbonyl, and
R
1
, R
3
, R
4
, R
5
 and R
6
have the abovementioned
meaning,

are cyclized in the presence of a hydrogenation
catalyst, in the presence of a basic reaction auxiliary

and in the presence of a diluent, or
b) open-chain hexadepsipeptides of the general
formula (IId) 



in which

R
1
, R
3
, R
4
, R
5
 and R
6
have the abovementioned
meaning,

are cyclized in the presence of a coupling reagent,
in the presence of a basic reaction auxiliary and

in the presence of a diluent.
</CLAIMS>
</TEXT>
</DOC>
